Clinical Trials in Baltimore

Showing 2041-2060 of 11,213 trials

Intent of Surgery for IPMN

NCT07216521

This multicenter retrospective observational cohort study seeks to: 1. Classify surgical intent in patients with resected Intraductal Papillary Mucinous Neoplasms (IPMN) and quantify the proportion of IPMN-associated cancers diagnosed as overt pancreatic cancer with incidental IPMN association on pathology. 2. Compare clinicopathologic features and outcomes between surveillance-detected and incidentally detected IPMN-derived pancreatic cancers. 3. Revise and redefine risk features limited to patients undergoing surgery for IPMN-related indications, identifying optimal predictors of malignant IPMN (high-grade dysplasia or invasive cancer).

Intraductal Papillary Mucinous Neoplasm

NYU Langone Health2,000 participantsStarted Sep 2025

Phoenix, Arizona, United States • Baltimore, Maryland, United States • Boston, Massachusetts, United States +11 more locations

COMPLETEDPhase 2< 1 mile

A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

NCT04103892

The clinical trial is a Phase 2, double-blind, randomized, placebo controlled study in Major Depressive Disorder (MDD) participants currently treated with antidepressant therapy. The objective of the study is to assess CLE-100 for the treatment of MDD in participants currently treated with standard antidepressant therapy.

Adjunctive Treatment of Major Depressive Disorder

Clexio Biosciences Ltd.146 participantsStarted Sep 2019

Bentonville, Arkansas, United States • Little Rock, Arkansas, United States • Little Rock, Arkansas, United States +43 more locations

Intent of Surgery for IPMN

A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

Find Trials by Condition in Baltimore

Impact of Iron Supplementation Treatment on Brain Iron Concentrations

Home Blood Pressure Telemonitoring LINKED With Community Health Workers to Improve Blood Pressure

Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

Targeted Multidomain (T-MD) Interventions for Complex Mild Traumatic Brain Injury (mTBI)

Natural History of Netherton Syndrome

Effects of Long-Duration Spaceflight on General and Spatial Cognition and Its Neural Basis

A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies

Integrative Medicine for Pain in Patients With Advanced Cancer Trial (IMPACT)

A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)

A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma

Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors

HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)

Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease